Skip to content

Pyxis Oncology, Inc.

Public company
Headquarters
BOSTON, Massachusetts
Ticker
PYXS
CIK
0001782223

WARN notices since 2024

0
None on record

Workers affected since 2024

0
Across 0 notices

Executive changes, last 12 months

3
2 appointments, 1 departure

Last event

Sep 8, 2026
Executive appointmentCEO appointed: Thomas Civik

Workers affected over time

Cumulative workers in WARN notices since 2024

Not enough notices to chart yet.

Leadership

Role and personSinceChange
CEOThomas CivikSep 8, 2026Appointed
Lead Independent DirectorJohn FlavinSep 8, 2026Appointed
member of the Company’s Board and all committees on which he servedSanthosh Palani, Ph.D., CFASep 8, 2026Departed

Related companies

Same industry and state, with recent events.

  1. Executive appointment

    CEO appointed: Thomas Civik

    Thomas Civik was named Chief Executive Officer of Pyxis Oncology, Inc., effective September 4, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Chief Executive Officer

    Source: SEC 8-K, filed Sep 8, 2026

  2. Executive appointment

    Lead Independent Director appointed: John Flavin

    John Flavin was named Lead Independent Director of Pyxis Oncology, Inc., effective September 4, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: Lead Independent Director

    Source: SEC 8-K, filed Sep 8, 2026

  3. Executive departure

    member of the Company’s Board and all committees on which he served departs: Santhosh Palani, Ph.D., CFA

    Santhosh Palani, Ph.D., CFA, member of the Company’s Board and all committees on which he served of Pyxis Oncology, Inc., resigns the role, effective September 4, 2026. The company reported the change in an 8-K that cites Item 5.02.

    Role: member of the Company’s Board and all committees on which he served

    Source: SEC 8-K, filed Sep 8, 2026

Last verified Nov 8, 2026